» Articles » PMID: 21803732

Phosphate and FGF23 in Early CKD: on How to Tackle an Invisible Foe

Overview
Date 2011 Aug 2
PMID 21803732
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease.

Iorga C, Iorga C, Andreiana I, Bengulescu I, Constantin T, Strambu V Front Endocrinol (Lausanne). 2023; 14:1191914.

PMID: 38075043 PMC: 10703479. DOI: 10.3389/fendo.2023.1191914.


Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer.

Ghorbanihaghjo A, Argani H, Golmohamadi Z, Rashtchizadeh N, Mesgari Abbasi M, Bargahi N J Bone Metab. 2018; 25(3):153-159.

PMID: 30237994 PMC: 6135647. DOI: 10.11005/jbm.2018.25.3.153.


Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients.

Luedde M, Roy S, Hippe H, Cardenas D, Spehlmann M, Vucur M Sci Rep. 2018; 8(1):9750.

PMID: 29950701 PMC: 6021423. DOI: 10.1038/s41598-018-28201-7.


Study of Red Cell Fragility in Different Stages of Chronic Kidney Disease in Relation to Parathyroid Hormone.

Panda S, Mishra A, Jena M, Rout S, Mohapatra S J Clin Diagn Res. 2017; 11(8):BC29-BC32.

PMID: 28969115 PMC: 5620755. DOI: 10.7860/JCDR/2017/27344.10514.


Vascular calcification: When should we interfere in chronic kidney disease patients and how?.

Sharaf El Din U, Salem M, Abdulazim D World J Nephrol. 2016; 5(5):398-417.

PMID: 27648404 PMC: 5011247. DOI: 10.5527/wjn.v5.i5.398.